Nutraceutical composition
OwnerRudolph Cartwright, Leo Edward Hendricksinventors
Life of this patent
Estimating the term…
Abstract
Provided is a nutraceutical composition including a tripeptoid component, a flavonoid component, guanidine hydrochloride, α-lipoic acid, an amino acid component, a brazilin component, catalase, and, optionally, vitamin E ans selenium. The composition is effective to maintain normal blood sugar levels and normal levels of non-enzymatic protein glycosylation in a human.
Claims32
A nutraceutical composition comprising the following constituents:
- 1) a tripeptide component,
- 2) guanidine hydrochloride,
- 3) α-lipoic acid,
- 4) a brazilin component,
- 5) an amino acid component,
- 6) a flavonoid component, and
- 7) catalase;
- wherein each constituent is present in an effective proportion such that, when administered to a human in a blood sugar and glycosylation maintaining effective amount, the nutraceutical composition is effective to maintain normal blood sugar levels and normal levels of non-enzymatic protein glycosylation in the human.
A nutraceutical composition in the form of first and second oral solid dosage forms wherein the first solid oral dosage form comprises:
- 1) from about 95 to about 110 pbw tripeptide component that consists essentially of glutathione,
- 2) from about 5 to about 15 pbw guanidine hydrochloride,
- 3) from about 100 to about 115 pbw of flavonoid component that consists essentially of quercetin and silymarin, and
- wherein the second solid oral dosage form comprises:
- 1) from about 95 to about 110 pbw tripeptide component that consists essentially of glutathione,
- 2) from about 10 to about 20 pbw α-lipoic acid,
- 3) from about 20 to about 30 pbw lysine,
- 4) from about 45 to about 55 pbw of a brazilin component,
- 5) from about 10 to about 20 pbw of flavonoid component that consists essentially of rutin, and
- 6) from about 10 to about 20 pbw of catalase.
A method for maintaining normal blood sugar levels and normal levels of non-enzymatic protein glycosylation in a human comprising the step of administering to the human a blood sugar and glycosylation maintaining effective amount of a nutraceutical composition comprising the following constituents:
- 1) a tripeptide component
- 2) guanidine hydrochloride,
- 3) α-lipoic acid,
- 4) a brazilin component,
- 5) an amino acid component,
- 6) a flavonoid component, and
- 7) catalase,
- wherein each of the constituents is present in the composition in an effective proportion.
A method for maintaining normal blood sugar levels and normal levels of non-enzymatic protein glycosylation in a human comprising the step of administering a blood sugar and glycosylation maintaining effective amount of a nutraceutical composition comprising the following constituents in their approximate effective proportions:
- 1) from about 190 to about 210 pbw of a tripeptide component,
- 2) from about 120 to about 130 pbw of a flavonoid component,
- 3) from about 5 to about 15 pbw guanidine hydrochloride,
- 4) from about 10 to about 20 pbw α-lipoic acid,
- 5) from about 20 to about 30 pbw lysine,
- 6) from about 45 to about 55 pbw brazilin component, and
- 7) from about 10 to about 20 pbw catalase.
Dependencies are inferred from the claim text.